Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hana
Hana Billauer, Jerusalem IL
| Patent application number | Description | Published |
|---|---|---|
| 20110293519 | MOLECULAR IMAGING AGENTS - Provided is radiolabeled ammonium salts and uses thereof as myocardial perfusion agents in molecular imaging. | 12-01-2011 |
Hana Breznova, Vsetin CZ
| Patent application number | Description | Published |
|---|---|---|
| 20090185329 | Electrolytic Capacitor Anode Treated with an Organometallic Compound - An electrolytic capacitor that contains an anodically oxidized anode that is incorporated with an additional metallic element is provided. More specifically, the metallic element is built into the valve metal pentoxide of the dielectric layer. In one particular embodiment, the addition of the metallic element results in a niobium pentoxide dielectric that contains closely packed units of O atoms, Nb | 07-23-2009 |
| 20090185330 | Sintered Anode Pellet Etched with an Organic Acid for Use in an Electrolytic Capacitor - An electrolytic capacitor anode etched with an organic acid prior to anodic oxidation of the anode to create the dielectric layer. Without intending to be limited by theory, it is believed that the organic acid can etch away at least a portion of any oxides on the anode. This provides a relatively uniform surface for the creation of the dielectric, which in turn leads to a dielectric layer having a substantially uniform thickness and homogeneous amorphous structure and thus improved leakage current and stability. The organic acid may also have other residual benefits, such as removing any metallic impurities from the surface of the anode. | 07-23-2009 |
| 20090185941 | Sintered Anode Pellet Treated with a Surfactant for Use in an Electrolytic Capacitor - An electrolytic capacitor anode treated with a surfactant during anodic oxidation is provided. Without intending to be limited by theory, it is believed that the surfactant may lower the surface tension of an electrolyte, which inhibits the clustering of grown oxides and allows the dielectric layer to become more homogeneous and uniformly spread over the anode body. The resulting dielectric layer may thus have a substantially homogeneous thickness, smooth surface, and improved leakage current stability. | 07-23-2009 |
Hana Brusova, Praha CZ
| Patent application number | Description | Published |
|---|---|---|
| 20120041227 | NEW SALTS OF DESVENLAFAXINE AND A METHOD OF THEIR PREPARATION - The invention deals with new salts of the desvenlafaxine base of formula (I) with oxalic acid, the new salts being the hydrogen oxalate of formula (II) in the proportion of desvenlafaxine:oxalic acid of 1:1 and hemioxalate of formula (III) in the proportion of desvenlafaxine:oxalic acid of 2:1. | 02-16-2012 |
Hana Chockler, Haifa IL
| Patent application number | Description | Published |
|---|---|---|
| 20090106737 | Using Cross-entropy to Test Executable Logic Code - A method for detecting the occurrence of rare events in an executable logic code includes assigning a first probability of a chance of traversal of one or more decision paths, in which each path connects two decision points defined by execution of the logic code. As a result of execution of the logic code, the decision paths traversed are evaluated to determine whether said traversal conforms to a predefined performance function. The performance function defines a goal to be achieved pursuant to the execution of the logic code. A second probability is assigned to the chance of traversal of at least one of said one or more decision paths to increase the likelihood that the one or more decision paths are traversed in a subsequent execution of the logic code in a closer conformity with the predefined performance function. | 04-23-2009 |
| 20090106740 | Replay of program executions using cross-entropy - A method for replay of program executions using cross-entropy is provided. The method comprises identifying a first sequence of decision points, wherein the first sequence represents a first execution of a logic code; identifying a second sequence of decision points, wherein the second sequence represents a second execution of the logic code; computing a distance between the first and second executions; and minimizing the distance between the first and second executions using cross-entropy, in response to determining that the second execution is not within a predetermined threshold distance of the first execution. | 04-23-2009 |
| 20090276379 | Using automatically generated decision trees to assist in the process of design and review documentation - An embodiment of this invention is to use automatically generated decision trees to assist in the design and review process. In one embodiment, the decision trees are automatically extracted from data describing a system (in case of design process) or a review artifact (in case of review process). In a further embodiment, the decision trees are then used in the design process, and the order of attributes in the decision tree suggests a new order for writing the design document. | 11-05-2009 |
| 20100131930 | Selective Code Coverage Instrumentation - Reporting on software test coverage, where a set of coverage tasks and a coverage task hierarchy have been established for a software under test (SUT). Establishing a coverage task subset, the subset including at least one coverage task hierarchy element at a level above the lowest coverage task hierarchy level. Identifying when, during a software test, a coverage task in the coverage task subset was completed. Outputting to a user the identity of those portions of the coverage task that have been completed. Refining the coverage task subset in one of the following fashions through the coverage task hierarchy in accordance with user input: depth first progression, breadth first progression. | 05-27-2010 |
| 20110202904 | Hierarchical aggregation system for advanced metering infrastructures - A coverage analysis tool may determine coverage in respect to heterogeneous coverage tasks associated with different hierarchy levels of a tasks hierarchy. The coverage analysis tool may iteratively refine coverage tasks to determine coverage of sub-tasks. In some cases, coverage tasks may be unrefined in order to reduce overhead of coverage analysis in performance of the software under test, such that the software under test may perform in an essentially similar manner as in non-testing mode. | 08-18-2011 |
| 20110218793 | CONCRETIZATION OF ABSTRACTED TRACES - A trace associated with an abstraction of a target device is utilized to guide an execution of the target device to be substantially similar to the trace. An execution of the target device determines a non-deterministic decision based on a probability function. The probability function is configured to increase the likelihood that the execution will be substantially similar to the abstracted trace. Cross-entropy method may be utilized to guide the execution of the target device. | 09-08-2011 |
| 20110218794 | CONCRETIZATION OF ABSTRACTED TRACES - An abstract trace may be defined based on a coverage goal. An execution of a System Under Test (SUT) is guided in accordance with the coverage goal. Non-deterministic decision, which correlates to receiving a stimulus to the SUT, is decided based on a probability function. After one or more executions, the probability function is modified based on a measurement of similarity between the abstract trace and each of the one or more executions. The modification of the probability function may be performed using on Cross-Entropy method. The modification is performed in order to cause determination of non-deterministic decisions in executions to better correlate with the abstract trace. In some exemplary embodiments, a determination whether the abstract trace is reachable is determined based on a rate of convergence of the executions to the abstract trace. | 09-08-2011 |
Hana Chodounska, Praha CZ
| Patent application number | Description | Published |
|---|---|---|
| 20120071453 | STEROIDE ANIONIC COMPOUNDS, METHOD OF THEIR PRODUCTION, USAGE AND PHARMACEUTICAL PREPARATION INVOLVING THEM - A compound with general formula I | 03-22-2012 |
Hana Frauenknecht, Kussnacht CH
| Patent application number | Description | Published |
|---|---|---|
| 20080264474 | Solar System and Method for the Operation Thereof - Disclosed is a solar system comprising a solar panel ( | 10-30-2008 |
Hana Giat, Talmon IL
| Patent application number | Description | Published |
|---|---|---|
| 20100095161 | TEST TOOL FOR CONCURRENT WEB SERVICES AND USER INTERFACE TESTING - A computer-executed test tool combines testing of an application at a user interface layer and a web services layer. The computer-executed test tool comprises a capture tool that records a web services test concurrently with recording of a user interface test. | 04-15-2010 |
Hana Giat, Taimon IL
| Patent application number | Description | Published |
|---|---|---|
| 20100083225 | Dynamic Autocompletion Tool - In at least some embodiments, a computing device includes a processor and a system memory coupled to said processor. The system memory stores an integrated development environment (IDE) and a dynamic autocompletion tool. When executed by the processor, the IDE provides a script editor. When executed by the processor, the dynamic autocompletion tool analyzes real-time content of a user application being executed to populate an autocompletion list for use with the IDE application. | 04-01-2010 |
Hana Giat, Flushing, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110283243 | DEDICATED ON-SCREEN CLOSED CAPTION DISPLAY - Methods and apparatus for displaying closed-captioning content on a display device. In response to determining that closed-captioning is desired, a display area of the display device is partitioned into non-overlapping portions. A first portion of the display area is configured to display the closed-captioning content and a second portion of the display area is configured to display a computer desktop. The closed-captioning content may be transformed by replacing at least some text in the closed-captioning content with at least one symbol based, at least in part, on a context of the at least some text in the closed-captioning content. | 11-17-2011 |
Hana Ishii, Tsukuba-Shi JP
| Patent application number | Description | Published |
|---|---|---|
| 20110262660 | CHALCOGENIDE-CONTAINING PRECURSORS, METHODS OF MAKING, AND METHODS OF USING THE SAME FOR THIN FILM DEPOSITION - Disclosed are chalcogenide-containing precursors for use in the manufacture of semiconductor, photovoltaic, LCD-TFT, or flat panel type devices. Also disclosed are methods of synthesizing the chalcogenide-containing precursors and vapor deposition methods, preferably thermal ALD, using the chalcogenide-containing precursors to form chalcogenide-containing films. | 10-27-2011 |
| 20120021590 | Tellurium Precursors for Film Deposition - Methods and compositions for depositing a tellurium-containing film on a substrate are disclosed. A reactor and at least one substrate disposed in the reactor are provided. A tellurium-containing precursor is provided and introduced into the reactor, which is maintained at a temperature ranging from approximately 20° C. to approximately 100° C. Tellurium is deposited on to the substrate through a deposition process to form a thin film on the substrate. | 01-26-2012 |
Hana Lukinsky, Portland, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20080305557 | Novel Applications of Acridinium Compounds and Derivatives in Homogeneous Assays - Chemiluminescent acridinium compounds are used in homogeneous assays to determine the concentration of an analyte in a sample without strong acid or strong base treatment. The chemiluminescent acridinium compounds include acridinium esters with electron donating functional groups at the C2 and/or C7 position on the acridinium nucleus to inhibit pseudo-base formation, or acridinium sulfonamides with or without electron donating functional groups at the C2 and/or C7 position on the acridinium nucleus. | 12-11-2008 |
| 20090029349 | Novel Applications of Acridinium Compounds and Derivatives in Homogeneous Assays - Chemiluminescent acridinium compounds are used in homogeneous assays to determine the concentration of an analyte in a sample without strong acid or strong base treatment. The chemiluminescent acridinium compounds include acridinium esters with electron donating functional groups at the C2 and/or C7 position on the acridinium nucleus to inhibit pseudo-base formation, or acridinium sulfonamides with or without electron donating functional groups at the C2 and/or C7 position on the acridinium nucleus. | 01-29-2009 |
Hana Petrickova, Praha CZ
| Patent application number | Description | Published |
|---|---|---|
| 20100145064 | METHOD FOR THE PREPARATION OF ZOLMITRIPTAN - A method for the preparation of zolmitriptan or its pharmaceutically acceptable salts, comprising isolation of a crystalline salt of zolmitriptan, its optional re-purification and conversion to the substance of formula (III). Zolmitriptan hydrochloride in the crystalline state. | 06-10-2010 |
| 20100267958 | METHOD FOR ISOLATION AND PURIFICATION OF MONTELUKAST - A method of isolation of Montelukast of formula I from reaction mixtures, comprising conversion of the crude sub-stance to well-crystallizing salts with primary amines in the environment of at least one organic solvent and acetonitrile, followed by re-crystallization of these salts with simultaneous removal of chemical impurities and use of the chemically pure salts of Montelukast with primary amines for direct transformation to the pharmaceutically useful amorphous form of Montelukast sodium of formula II. | 10-21-2010 |
Hana Raslova, Le Coudray Montceaux FR
| Patent application number | Description | Published |
|---|---|---|
| 20100120663 | METHOD FOR INDUCING THROMBOPOIESIS - A regime or regimen for inducing the differentiation of multilineage myeloid progenitor cells (CFU-GEMM) into megakaryocyte progenitor cells and, optionally, into megakaryocytes, that are able to produce platelets both in vivo and in vitro, includes a step a) of administering a thus effective amount of erythropoietin, derivative or agonist thereof to multilinear myeloid progenitor cells. | 05-13-2010 |
Hana Shteiman, Nes Ziona IL
| Patent application number | Description | Published |
|---|---|---|
| 20100327511 | SYSTEMS AND METHODS OF PRINTING USING CONCATENATED MEDIA FEEDER DEVICES | 12-30-2010 |
Hana Stankova, Strakonice CZ
| Patent application number | Description | Published |
|---|---|---|
| 20080289387 | Method of manipulating and forming material at temperatures between solidus and liquidus - A method of manipulating and forming material where the material is a metal blank. The blank is inserted into an electromagnetic field that keeps it in levitation and heats it up to the temperature between solid state and liquid state. Temperature is measured by infrared thermometer. After the blank reaches the required temperature it is formed to the desired shape by external force. The temperature changes during the forming phase and this change can be controlled or uncontrolled. Forming of levitated blank is done by changing position of levitation device by inserting the blank between forming tools or levitated blank stays in place and forming tools move towards it and then the forming takes place. | 11-27-2008 |
Hana Stepankova, Cesky Brod CZ
| Patent application number | Description | Published |
|---|---|---|
| 20100228033 | METHOD OF MANUFACTURING 5-[2-CYCLOPROPYL-1-(2-FLUOROPHENYL)-2-OXOETHYL]-4,5,6,7-TETRAHYDROTHIENO[- 3,2-C]PYRIDIN-2-YL ACETATE (PRASUGREL) - A method of manufacturing 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate, known under the INN name prasugrel of formula (I), in which the substance of formula (VI) is reacted with a cyclopropyl magnesium halide to produce the substance of formula (V), which reacted with methanesulfonyl chloride to give the methanesulfonate of formula (IV), which is further reacted with the compound of formula (III) to be converted the substance of formula (II) and the latter is converted to the substance of formula (I) with an acetylation agent. | 09-09-2010 |
| 20110046389 | INTERMEDIATES FOR THE PREPARATION OF (3R, 4S)-1-(4-FLUOROPHENYL)-3-[(3S)-3-(4-FLUOROPHENYL)-3-HYDROXYPROPYL)]-4-(4-- HYDROXYPHENYL)-2-AZETIDINONE - A method for the preparation of (S)-alcohol oxazolidides of general formula II, in which PG represents hydrogen or a hydroxyl protecting group, such as trimethylsilyl, tert-butyldimethylsilyl, benzyloxycarbonyl, tert-butoxycarbonyl, benzyl, benzhydryl or trityl, in which a ketal oxazolidide of general formula III, where PG has the same meaning as above and R means an alkyl with 1-4 carbon atoms, linear or branched, such as methyl, ethyl, isopropyl or butyl, or R+R together represents a divalent alkyl, or substituted with 1 or 2 alkyl groups, e.g. 1,2-ethylene, 1,2-propylene, 1,2-butylene, 1,3-propylene or 2,2-dimethyl-1,3-propylene, is deprotected by the action of acidic reagents in a mixture of water and a water-miscible solvent in the temperature range of 0 to 100° C. (stage A), and the obtained ketone oxazolidide of general IV, in which PG has the same meaning as above, is reduced with asymmetrical reagents in an inert organic solvent in the temperature range of −30 to +40° C. (stage B). | 02-24-2011 |
| 20110282064 | METHOD FOR THE MANUFACTURE OF HIGHLY PURE PRASUGREL - The invention deals with preparation of the substance prasugrel, using 3-cyclopropyl-1-(2-fluorophenyl)-3-oxopropyl methanesulfonate for alkylation of 2-oxo-thienotetrahydropyridine, which may be in the form of a salt, e.g. with hydrochloric acid or p-toluenesulfonic acid. The resulting compound of formula II is acylated, preferably with acetanhydride, preferably directly in the reaction mixture without isolation, and the produced prasugrel of formula I can then be crystallized directly from the reaction mixture. | 11-17-2011 |
Hana Tkadlecková, Brno CZ
| Patent application number | Description | Published |
|---|---|---|
| 20100093849 | OXALIPLATIN PHARMACEUTICAL COMPOSITION WITH ALCOHOLIC SUGAR-BASED BUFFER - A pharmaceutical composition, intended particularly for potential administration and for treatment of tumor diseases sensitive to oxaliplatinum, comprises oxaliplatinum as the active compound, a pharmaceutically acceptable aqueous solvent and a stabilizing agent in stabilizingly effective amount. The stabilizing agent includes at least one compound selected from the group consisting of acids derived from neutral alcoholic sugars, lactones of these acids and salts of these acids. In a method of producing such a pharmaceutical composition, oxaliplatinum is dissolved in an aqueous solvent, whereupon to the obtained oxaliplatinum solution is added at least one acid derived from a neutral alcoholic sugar and/or at least one lactone of these acids and/or at least one salt of these acids, and optionally the pH value of the solution is adjusted by addition of an alkali metal hydroxide and/or an alkali earth metal hydroxide to pH 3.5-6.5, whereupon the obtained solution is sterilized and filled into individual package units and optionally inertized with nitrogen or argon. | 04-15-2010 |
Hana Tkadlecková, Brno CZ
| Patent application number | Description | Published |
|---|---|---|
| 20100093849 | OXALIPLATIN PHARMACEUTICAL COMPOSITION WITH ALCOHOLIC SUGAR-BASED BUFFER - A pharmaceutical composition, intended particularly for potential administration and for treatment of tumor diseases sensitive to oxaliplatinum, comprises oxaliplatinum as the active compound, a pharmaceutically acceptable aqueous solvent and a stabilizing agent in stabilizingly effective amount. The stabilizing agent includes at least one compound selected from the group consisting of acids derived from neutral alcoholic sugars, lactones of these acids and salts of these acids. In a method of producing such a pharmaceutical composition, oxaliplatinum is dissolved in an aqueous solvent, whereupon to the obtained oxaliplatinum solution is added at least one acid derived from a neutral alcoholic sugar and/or at least one lactone of these acids and/or at least one salt of these acids, and optionally the pH value of the solution is adjusted by addition of an alkali metal hydroxide and/or an alkali earth metal hydroxide to pH 3.5-6.5, whereupon the obtained solution is sterilized and filled into individual package units and optionally inertized with nitrogen or argon. | 04-15-2010 |
Hana Trefna, Vastra Frolunda SE
| Patent application number | Description | Published |
|---|---|---|
| 20100010596 | METHOD AND SYSTEM RELATING TO HYPERTHERMIA - A method and system for selective heating of an object based on a model of the object, the method comprising the steps of: modeling of a wave front of a source, which wave front is propagated through the model object from a virtual antenna placed in the model of the specific region where heating is desired, simulating a radiated field and measuring the same using computer models of surrounding antenna system, time-reversing, transferring and synthesizing the signal in a real system, transmitting by a real antenna system the field in a time reversed order, and refocusing of time reversed signal at the original s the invariance of a wave equation under time reversal. | 01-14-2010 |
Hana Tuby, Ra'Anana IL
| Patent application number | Description | Published |
|---|---|---|
| 20120041521 | LOW-LEVEL ENERGY LASER THERAPY - Methods and systems ( | 02-16-2012 |
Hana Vaisocherova, Prague CZ
| Patent application number | Description | Published |
|---|---|---|
| 20100099160 | DUAL-FUNCTIONAL NONFOULING SURFACES AND MATERIALS - Dual-functional nonfouling surfaces and materials, methods for making dual-functional nonfouling surfaces and materials, and devices that include dual-functional nonfouling surfaces and materials. The dual-functional surfaces are nonfouling surfaces that resist non-specific protein adsorption and cell adhesion. The dual-functional surfaces and materials include covalently coupled biomolecules (e.g., target binding partners) that impart specific biological activity thereto. The surfaces and materials are useful in medical diagnostics, biomaterials and bioprocessing, tissue engineering, and drug delivery. | 04-22-2010 |
Hana Vranova, Brno CZ
| Patent application number | Description | Published |
|---|---|---|
| 20110284374 | ELECTROCHEMICAL SENSOR COMPRISING A SUBSTRATE AND AN INJECTION MOULDED REACTION VESSEL AND METHOD OF ITS MANUFACTURE - An electrochemical sensor is described, containing a sensor substrate and at least one set of electrodes comprising a working electrode, a reference electrode and optionally an auxiliary electrode, further containing at least one reaction vessel, which is tightly connected to the sensor substrate and inside which is located at least one working electrode, whereas at least a part of the sensor substrate forms a vessel bottom. The vessel can contain a lid and also other preferred embodiments are described. The invention further describes a method of manufacture of the electrochemical sensor with the integrated reaction vessel, particularly by injection moulding. | 11-24-2011 |